Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide-Reference-Cited by-同舟云学术

Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide

Published:2020-10-23 Issue:4 Volume:70 Page:989-1000
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Oweida Ayman J.,Mueller Adam C.,Piper Miles,Milner Dallin,Van Court Benjamin,Bhatia Shilpa,Phan Andy,Bickett Thomas,Jordan Kimberly,Proia Theresa,Schulick Richard,Messersmith Wells A.,Del Chiaro Marco,Clambey Eric,Gough Michael J.,Williams Jason,Hansen Kirk,Goodman Karyn,Karam Sana D.^ORCID

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-020-02701-w.pdf

Reference53 articles.

1. Garrido-Laguna I, Hidalgo M (2015) Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat Rev Clin Oncol 12(6):319–334

2. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA A Cancer J Clin 69(1):7–34

3. Bailey P et al (2016) Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531(7592):47–52